Waddell & Reed Financial’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
CS
RP
BG
EAM
CTA
ECP
Waddell & Reed Financial's EVH Position: Q3 2019 in Review
Waddell & Reed Financial sold out of Evolent Health (EVH) in Q3 2019, closing a stake of 1,010,599 shares — an estimated $8.03M sold.
Waddell & Reed Financial first reported a position in EVH in Q3 2015 and held it in 16 quarters. The position peaked at $51.9M in Q4 2018. 174 funds tracked by Wall St. Rank hold EVH as of Q3 2019.
- Waddell & Reed Financial reported no remaining Evolent Health position as of Q3 2019 after selling out during the quarter.
- Waddell & Reed Financial sold 1,010,599 Evolent Health shares in Q3 2019, an estimated $8.03M.
- Waddell & Reed Financial first reported a position in Evolent Health in Q3 2015 and held it in 16 quarters.
- Waddell & Reed Financial's Evolent Health position peaked at $51.9M in Q4 2018.
- 174 funds tracked by Wall St. Rank held Evolent Health as of Q3 2019.
Based on Waddell & Reed Financial's 13F filing for Q3 2019, filed 14 Nov 2019.